The need for standardization of antiretinal antibody detection and measurement.

Autoimmune retinopathy. Am J Ophthalmol (2013) 1.08

Outer retinal structure in patients with acute zonal occult outer retinopathy. Am J Ophthalmol (2011) 1.01

Potential Sources and Roles of Adaptive Immunity in Age-Related Macular Degeneration: Shall We Rename AMD into Autoimmune Macular Disease? Autoimmune Dis (2014) 0.91

The need for standardization of antiretinal antibody detection and measurement. Am J Ophthalmol (2009) 0.90

Autoimmune retinopathy in systemic lupus erythematosus: histopathologic features. Open Ophthalmol J (2009) 0.79

Consensus on the Diagnosis and Management of Nonparaneoplastic Autoimmune Retinopathy Using a Modified Delphi Approach. Am J Ophthalmol (2016) 0.79

Cancer-associated retinopathy as the leading symptom in colon cancer. Clin Case Rep (2015) 0.78

Serum Autoantibody Profiling of Patients with Paraneoplastic and Non-Paraneoplastic Autoimmune Retinopathy. PLoS One (2016) 0.75

The need for standardization of antiretinal antibody detection and measurement. Am J Ophthalmol (2009) 0.75

The enigma of autoimmune retinopathy. Int Ophthalmol Clin (2015) 0.75

B Cell Anomalies in Autoimmune Retinopathy (AIR). Invest Ophthalmol Vis Sci (2017) 0.75

Recoverin-associated retinopathy: a clinically and immunologically distinctive disease. Am J Ophthalmol (1998) 2.89

Autoimmune retinopathy: patients with antirecoverin immunoreactivity and panretinal degeneration. Arch Ophthalmol (2000) 2.65

Cancer-associated retinopathy (CAR syndrome) with antibodies reacting with retinal, optic-nerve, and cancer cells. N Engl J Med (1989) 2.02

Clinical and electrophysiologic characterization of paraneoplastic and autoimmune retinopathies associated with antienolase antibodies. Am J Ophthalmol (2005) 1.89

Autoantibodies against retinal proteins in paraneoplastic and autoimmune retinopathy. BMC Ophthalmol (2004) 1.83

Blindness caused by photoreceptor degeneration as a remote effect of cancer. Am J Ophthalmol (1976) 1.65

The occurrence of serum autoantibodies against enolase in cancer-associated retinopathy. Clin Immunol Immunopathol (1996) 1.54

Selective immunohistochemical staining in the paraneoplastic retinopathy syndrome. Ophthalmology (1992) 1.49

The cancer-associated retinopathy antigen is a recoverin-like protein. Invest Ophthalmol Vis Sci (1992) 1.44

A clinical triad to diagnose paraneoplastic retinopathy. Ann Neurol (1990) 1.43

Cancer-associated retinopathy. Arch Ophthalmol (1987) 1.39

Recoverin, a photoreceptor-specific calcium-binding protein, is expressed by the tumor of a patient with cancer-associated retinopathy. Proc Natl Acad Sci U S A (1995) 1.35

Apoptotic retinal cell death induced by antirecoverin autoantibodies of cancer-associated retinopathy. Invest Ophthalmol Vis Sci (1997) 1.30

Photoreceptor degeneration. Possible autoimmune disorder. Arch Ophthalmol (1983) 1.29

Anti-enolase-alpha autoantibodies in cancer-associated retinopathy: epitope mapping and cytotoxicity on retinal cells. J Autoimmun (1998) 1.28

Autoantibodies specific for alpha-enolase in systemic autoimmune disorders. J Rheumatol (2000) 1.27

Association of antiretinal antibodies and cystoid macular edema in patients with retinitis pigmentosa. Am J Ophthalmol (1999) 1.25

Autoantibody-induced apoptosis as a possible mechanism of autoimmune retinopathy. Autoimmun Rev (2003) 1.24

Autoimmune retinopathy in the absence of cancer. Am J Ophthalmol (1997) 1.22

Antibodies to recoverin induce apoptosis of photoreceptor and bipolar cells in vivo. J Autoimmun (1998) 1.22

Complete amino acid sequence of the neurone-specific gamma isozyme of enolase (NSE) from human brain and comparison with the non-neuronal alpha form (NNE). Eur J Biochem (1988) 1.21

The role of anti-alpha-enolase autoantibodies in pathogenicity of autoimmune-mediated retinopathy. J Clin Immunol (2007) 1.19

Proteomics-based identification of alpha-enolase as a tumor antigen in non-small lung cancer. Cancer Sci (2007) 1.17

Treatment of paraneoplastic visual loss with intravenous immunoglobulin: report of 3 cases. Arch Ophthalmol (1999) 1.15

Mechanisms of photoreceptor cell death in cancer-associated retinopathy. Invest Ophthalmol Vis Sci (2001) 1.11

Prevalence and clinico-serological correlations of anti-alpha-enolase, anti-C1q, and anti-dsDNA antibodies in patients with systemic lupus erythematosus. J Rheumatol (2006) 1.10

Frequency of anti-retinal antibodies in normal human serum. J Neuroophthalmol (2008) 1.09

Anti-retinal auto-antibodies in Vogt-Koyanagi-Harada syndrome, Behcet's disease, and sympathetic ophthalmia. Ophthalmology (1985) 1.07

Antibody reactions with retina and cancer-associated antigens in 10 patients with cancer-associated retinopathy. Arch Ophthalmol (1993) 1.06

Paraneoplastic retinopathy associated with antiretinal bipolar cell antibodies in cutaneous malignant melanoma. Ophthalmology (1994) 1.05

Mechanism of CAR syndrome: anti-recoverin antibodies are the inducers of retinal cell apoptotic death via the caspase 9- and caspase 3-dependent pathway. J Neuroimmunol (2002) 1.05

Cancer-associated retinopathy induced by both anti-recoverin and anti-hsc70 antibodies in vivo. Invest Ophthalmol Vis Sci (1999) 1.04

Cellular targets of anti-alpha-enolase autoantibodies of patients with autoimmune retinopathy. J Autoimmun (2004) 1.04

Anti-recoverin antibodies induce an increase in intracellular calcium, leading to apoptosis in retinal cells. J Autoimmun (2006) 1.03

Autoantibodies to transducin in a patient with melanoma-associated retinopathy. Am J Ophthalmol (2002) 1.02

Management and monitoring of cancer-associated retinopathy. Arch Ophthalmol (1992) 1.00

Recoverin, but not visinin, is an autoantigen in the human retina identified with a cancer-associated retinopathy. Invest Ophthalmol Vis Sci (1993) 0.99

Antiretinal antibodies in serum of patients with age-related macular degeneration. Ophthalmology (1991) 0.99

Electroretinographic abnormalities in multiple sclerosis: possible role for retinal autoantibodies. Doc Ophthalmol (2006) 0.99

Association of antiretinal antibodies in acute annular outer retinopathy. Arch Ophthalmol (2008) 0.96

Cancer-associated retinopathy. Arch Ophthalmol (1999) 0.96

Long-term persistence of antirecoverin antibodies in endometrial cancer-associated retinopathy. Arch Ophthalmol (1998) 0.96

Paraneoplastic retinopathy associated with uterine sarcoma. Gynecol Oncol (1995) 0.96

Investigations of antiretinal antibodies in pigmentary retinopathy and other retinal degenerations. Trans Am Ophthalmol Soc (1996) 0.93

Human antiretinal antibodies in toxoplasma retinochoroiditis. Br J Ophthalmol (1998) 0.93

Anti-recoverin antibodies cause the apoptotic death of mammalian photoreceptor cells in vitro. J Neurosci Res (1999) 0.93

Paraneoplastic retinopathy: a novel autoantibody reaction associated with small-cell lung carcinoma. J Neuroophthalmol (1997) 0.92

Immunopathology of ocular onchocerciasis. 2. Anti-retinal autoantibodies in serum and ocular fluids. Ophthalmology (1987) 0.92

Müller cell-specific autoantibodies in a patient with progressive loss of vision. Invest Ophthalmol Vis Sci (1998) 0.91

Recoverin and Hsc 70 are found as autoantigens in patients with cancer-associated retinopathy. Invest Ophthalmol Vis Sci (1999) 0.90

The 22-kDa antigen in optic nerve and retinal diseases. J Neuroophthalmol (1999) 0.89

Cancer-associated retinopathy in a patient with endometrial cancer. Am J Ophthalmol (1996) 0.88

Successful treatment of cancer-associated retinopathy with alemtuzumab. J Neurooncol (2007) 0.88

Tubby-like protein 1 as an autoantigen in cancer-associated retinopathy. J Neuroimmunol (2000) 0.87

Autoantibodies to p75/LEDGF, a cell survival factor, found in patients with atypical retinal degeneration. J Autoimmun (2006) 0.87

Retinal dysfunction in cancer-associated retinopathy is improved by Ca(2+) antagonist administration and dark adaptation. Invest Ophthalmol Vis Sci (2001) 0.82

Intraperitoneal cultivation of small-cell carcinoma induces expression of the retinal cancer-associated retinopathy antigen. Arch Ophthalmol (1993) 0.81

Macular and retinal dysfunction of unknown origin in adults with normal fundi: evidence for an autoimmune pathophysiology. Exp Mol Pathol (2007) 0.81

Fluorescein angiographic findings in a case of cancer-associated retinopathy. Retina (1999) 0.78

Antibody indications of secondary and superimposed retinal hypersensitivity in retinitis pigmentosa. Am J Ophthalmol (1991) 0.77

Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol (2005) 13.50

Adult-onset primary open-angle glaucoma caused by mutations in optineurin. Science (2002) 6.53

TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27/STAT1. Nat Med (2007) 5.41

Genetic variants near TIMP3 and high-density lipoprotein-associated loci influence susceptibility to age-related macular degeneration. Proc Natl Acad Sci U S A (2010) 4.30

In-frame deletion in a novel centrosomal/ciliary protein CEP290/NPHP6 perturbs its interaction with RPGR and results in early-onset retinal degeneration in the rd16 mouse. Hum Mol Genet (2006) 3.90

Seven new loci associated with age-related macular degeneration. Nat Genet (2013) 3.81

Identification of a novel adult-onset primary open-angle glaucoma (POAG) gene on 5q22.1. Hum Mol Genet (2005) 3.56

E2-2 protein and Fuchs's corneal dystrophy. N Engl J Med (2010) 3.31

Management of autoimmune retinopathies with immunosuppression. Arch Ophthalmol (2009) 2.97

Identification of the gene (BBS1) most commonly involved in Bardet-Biedl syndrome, a complex human obesity syndrome. Nat Genet (2002) 2.94

Prevalence of disease-causing mutations in families with autosomal dominant retinitis pigmentosa: a screen of known genes in 200 families. Invest Ophthalmol Vis Sci (2006) 2.93

Cutting edge: NKT cells constitutively express IL-23 receptor and RORgammat and rapidly produce IL-17 upon receptor ligation in an IL-6-independent fashion. J Immunol (2008) 2.90

CRB1 is essential for external limiting membrane integrity and photoreceptor morphogenesis in the mammalian retina. Hum Mol Genet (2003) 2.77

Effective gene therapy with nonintegrating lentiviral vectors. Nat Med (2006) 2.70

Retinal degeneration 12 (rd12): a new, spontaneously arising mouse model for human Leber congenital amaurosis (LCA). Mol Vis (2005) 2.55

Toxoplasma gondii in the peripheral blood of patients with acute and chronic toxoplasmosis. Br J Ophthalmol (2010) 2.50

A comprehensive mutation analysis of RP2 and RPGR in a North American cohort of families with X-linked retinitis pigmentosa. Am J Hum Genet (2002) 2.29

Autologous mesenchymal stem cells produce reverse remodelling in chronic ischaemic cardiomyopathy. Eur Heart J (2009) 2.29

Mutations in the inosine monophosphate dehydrogenase 1 gene (IMPDH1) cause the RP10 form of autosomal dominant retinitis pigmentosa. Hum Mol Genet (2002) 2.26

Fundus autofluorescence imaging of the white dot syndromes. Arch Ophthalmol (2010) 2.26

Overall and cancer related mortality among patients with ocular inflammation treated with immunosuppressive drugs: retrospective cohort study. BMJ (2009) 2.23

BIGH3 mutation spectrum in corneal dystrophies. Invest Ophthalmol Vis Sci (2002) 2.19

Digenic inheritance of early-onset glaucoma: CYP1B1, a potential modifier gene. Am J Hum Genet (2002) 2.13

The nob2 mouse, a null mutation in Cacna1f: anatomical and functional abnormalities in the outer retina and their consequences on ganglion cell visual responses. Vis Neurosci (2006) 2.10

Effective tumor treatment targeting a melanoma/melanocyte-associated antigen triggers severe ocular autoimmunity. Proc Natl Acad Sci U S A (2008) 2.07

Cone photoreceptor function loss-3, a novel mouse model of achromatopsia due to a mutation in Gnat2. Invest Ophthalmol Vis Sci (2006) 2.05

Spectrum and frequency of mutations in IMPDH1 associated with autosomal dominant retinitis pigmentosa and leber congenital amaurosis. Invest Ophthalmol Vis Sci (2006) 1.96

Intraocular lymphoma. Curr Opin Ophthalmol (2002) 1.96

Clinical and electrophysiologic characterization of paraneoplastic and autoimmune retinopathies associated with antienolase antibodies. Am J Ophthalmol (2005) 1.89

Birdshot chorioretinopathy. Surv Ophthalmol (2005) 1.87

Methods for identifying long-term adverse effects of treatment in patients with eye diseases: the Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Cohort Study. Ophthalmic Epidemiol (2008) 1.87

Cytomegalovirus infection and the risk of mortality and frailty in older women: a prospective observational cohort study. Am J Epidemiol (2010) 1.85

Genomic rearrangements of the PRPF31 gene account for 2.5% of autosomal dominant retinitis pigmentosa. Invest Ophthalmol Vis Sci (2006) 1.85

Ocular and systemic autoimmunity after successful tumor-infiltrating lymphocyte immunotherapy for recurrent, metastatic melanoma. Ophthalmology (2009) 1.78

Cyclosporine for ocular inflammatory diseases. Ophthalmology (2010) 1.75

CRB1 mutation spectrum in inherited retinal dystrophies. Hum Mutat (2004) 1.75

Sympathetic ophthalmia: what have we learned? Am J Ophthalmol (2009) 1.73

Tachyphylaxis after intravitreal bevacizumab for exudative age-related macular degeneration. Retina (2009) 1.67

Innate immunity in the retina: Toll-like receptor (TLR) signaling in human retinal pigment epithelial cells. J Neuroimmunol (2004) 1.65

Identification of disease-causing mutations in autosomal dominant retinitis pigmentosa (adRP) using next-generation DNA sequencing. Invest Ophthalmol Vis Sci (2011) 1.63

Next generation sequencing-based molecular diagnosis of retinitis pigmentosa: identification of a novel genotype-phenotype correlation and clinical refinements. Hum Genet (2013) 1.63

Premature truncation of a novel protein, RD3, exhibiting subnuclear localization is associated with retinal degeneration. Am J Hum Genet (2006) 1.63

Mfrp, a gene encoding a frizzled related protein, is mutated in the mouse retinal degeneration 6. Hum Mol Genet (2002) 1.63

Adverse effects of smoking on patients with ocular inflammation. Br J Ophthalmol (2010) 1.61

Mutations in the X-linked retinitis pigmentosa genes RPGR and RP2 found in 8.5% of families with a provisional diagnosis of autosomal dominant retinitis pigmentosa. Invest Ophthalmol Vis Sci (2013) 1.60

Methotrexate for ocular inflammatory diseases. Ophthalmology (2009) 1.58

Targeted high-throughput DNA sequencing for gene discovery in retinitis pigmentosa. Adv Exp Med Biol (2010) 1.58

Identification and subcellular localization of the RP1 protein in human and mouse photoreceptors. Invest Ophthalmol Vis Sci (2002) 1.58

Rapid, noninvasive detection of diabetes-induced retinal metabolic stress. Arch Ophthalmol (2008) 1.57

Long-term risk of malignancy among patients treated with immunosuppressive agents for ocular inflammation: a critical assessment of the evidence. Am J Ophthalmol (2008) 1.56

A double-masked, randomized study to investigate the safety and efficacy of daclizumab to treat the ocular complications related to Behçet's disease. Ocul Immunol Inflamm (2007) 1.53

Structural abnormalities of the cornea and lid resulting from collagen V mutations. Invest Ophthalmol Vis Sci (2006) 1.53

Mutations in a BTB-Kelch protein, KLHL7, cause autosomal-dominant retinitis pigmentosa. Am J Hum Genet (2009) 1.52

Progressive photoreceptor degeneration, outer segment dysplasia, and rhodopsin mislocalization in mice with targeted disruption of the retinitis pigmentosa-1 (Rp1) gene. Proc Natl Acad Sci U S A (2002) 1.51

Mouse models of age-related macular degeneration. Exp Eye Res (2005) 1.49

Vitreous cytokine levels. Ophthalmology (2003) 1.48

The effect of long-term intermittent trimethoprim/sulfamethoxazole treatment on recurrences of toxoplasmic retinochoroiditis. Am J Ophthalmol (2002) 1.48

Mutations in RPGR and RP2 account for 15% of males with simplex retinal degenerative disease. Invest Ophthalmol Vis Sci (2012) 1.47

Comprehensive molecular diagnosis of 179 Leber congenital amaurosis and juvenile retinitis pigmentosa patients by targeted next generation sequencing. J Med Genet (2013) 1.47

Complement component C5a promotes expression of IL-22 and IL-17 from human T cells and its implication in age-related macular degeneration. J Transl Med (2011) 1.47

Protean manifestations of pediatric neurosarcoidosis. Can J Ophthalmol (2009) 1.45

Azathioprine for ocular inflammatory diseases. Am J Ophthalmol (2009) 1.44

Ocular manifestations of multiple sclerosis. Curr Opin Ophthalmol (2005) 1.42

Evaluating teaching methods of cataract surgery: validation of an evaluation tool for assessing surgical technique of capsulorhexis. J Cataract Refract Surg (2012) 1.42

Serpiginous choroiditis. Surv Ophthalmol (2005) 1.41

The Gly56Arg mutation in NR2E3 accounts for 1-2% of autosomal dominant retinitis pigmentosa. Mol Vis (2007) 1.41

CRYBA4, a novel human cataract gene, is also involved in microphthalmia. Am J Hum Genet (2006) 1.41

Mycophenolate mofetil for ocular inflammation. Am J Ophthalmol (2009) 1.41

Adult ovarian retinoblastoma genomic profile distinct from prior childhood eye tumor. Arch Ophthalmol (2011) 1.39

Identification of a rare coding variant in complement 3 associated with age-related macular degeneration. Nat Genet (2013) 1.39

International Uveitis Study Group (IUSG): clinical classification of uveitis. Ocul Immunol Inflamm (2008) 1.38

Cutting edge: in vivo blockade of human IL-2 receptor induces expansion of CD56(bright) regulatory NK cells in patients with active uveitis. J Immunol (2005) 1.36

Transforming growth factor-beta induces expression of vascular endothelial growth factor in human retinal pigment epithelial cells: involvement of mitogen-activated protein kinases. J Cell Physiol (2003) 1.35

Epidemiology and course of disease in childhood uveitis. Ophthalmology (2009) 1.35

Syphilitic outer retinopathy. Ocul Immunol Inflamm (2013) 1.34

Detailed analysis of retinal function and morphology in a patient with autosomal recessive bestrophinopathy (ARB). Doc Ophthalmol (2008) 1.33

Asteroid hyalosis in an autopsy population: The University of California at Los Angeles (UCLA) experience. Arch Ophthalmol (2005) 1.30

Spatial and temporal expression of MFRP and its interaction with CTRP5. Invest Ophthalmol Vis Sci (2006) 1.30

CTRP5 is a membrane-associated and secretory protein in the RPE and ciliary body and the S163R mutation of CTRP5 impairs its secretion. Invest Ophthalmol Vis Sci (2006) 1.29

Orbital myositis: diagnosis and management. Curr Allergy Asthma Rep (2009) 1.29

Hypomethylation of the IL17RC promoter associates with age-related macular degeneration. Cell Rep (2012) 1.28

BBS genotype-phenotype assessment of a multiethnic patient cohort calls for a revision of the disease definition. Hum Mutat (2011) 1.28

Retinal degeneration associated with RDH12 mutations results from decreased 11-cis retinal synthesis due to disruption of the visual cycle. Hum Mol Genet (2005) 1.26

Waldenström's macroglobulinemia-associated retinopathy. Ophthalmology (2004) 1.26

Ocular inflammation in Behçet disease: incidence of ocular complications and of loss of visual acuity. Am J Ophthalmol (2008) 1.23

Inflammatory cytokines regulate microRNA-155 expression in human retinal pigment epithelial cells by activating JAK/STAT pathway. Biochem Biophys Res Commun (2010) 1.23

Retinal morphological changes of patients with X-linked retinoschisis evaluated by Fourier-domain optical coherence tomography. Arch Ophthalmol (2008) 1.21

Genotype-phenotype correlation in 440 patients with NPHP-related ciliopathies. Kidney Int (2011) 1.21

CRYBA3/A1 gene mutation associated with suture-sparing autosomal dominant congenital nuclear cataract: a novel phenotype. Invest Ophthalmol Vis Sci (2004) 1.21

Melanoma-associated retinopathy: a paraneoplastic autoimmune complication. Arch Ophthalmol (2009) 1.20

Naturally occurring interference in Luminex assays for HLA-specific antibodies: characteristics and resolution. Hum Immunol (2009) 1.19

Rd9 is a naturally occurring mouse model of a common form of retinitis pigmentosa caused by mutations in RPGR-ORF15. PLoS One (2012) 1.19

Sequencing arrays for screening multiple genes associated with early-onset human retinal degenerations on a high-throughput platform. Invest Ophthalmol Vis Sci (2005) 1.18

High-resolution homozygosity mapping is a powerful tool to detect novel mutations causative of autosomal recessive RP in the Dutch population. Invest Ophthalmol Vis Sci (2011) 1.18

Differential regulation of microRNA-146a and microRNA-146b-5p in human retinal pigment epithelial cells by interleukin-1β, tumor necrosis factor-α, and interferon-γ. Mol Vis (2013) 1.16

Characterization of the Crumbs homolog 2 (CRB2) gene and analysis of its role in retinitis pigmentosa and Leber congenital amaurosis. Mol Vis (2005) 1.16

CRYBB1 mutation associated with congenital cataract and microcornea. Mol Vis (2005) 1.16